Burroughs Amy L.'s Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Jan 16, 2026
- Accession no.
- 0001872564-26-000004
- Filed
- Jan 16, 2026
- Trade date
- Jan 14-15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $2.55M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burroughs Amy L.CIK 0001872564 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | Common Stock | AGrant or awardAcquired | +150,000 | $0.00 | $0 | 288,976 | Direct | |
| Jan 15, 2026 | Common Stock | MOption exerciseAcquired | +27,083 | $4.64 | +$125,665.12 | 316,059 | Direct | |
| Jan 15, 2026 | Common Stock | MOption exerciseAcquired | +27,083 | $4.64 | +$125,665.12 | 343,142 | Direct | |
| Jan 15, 2026 | Common Stock | MOption exerciseAcquired | +14,583 | $4.64 | +$67,665.12 | 357,725 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −61,228 | $37.02 | −$2,266,660.56 | 296,497 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −7,521 | $37.53 | −$282,263.13 | 288,976 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | Common Stock | AGrant or awardAcquired | +300,000 | $0.00 | $0 | 300,000 | Direct | |
| Jan 15, 2026 | Common Stock | MOption exerciseDisposed | −27,083 | $0.00 | $0 | 1,026,366 | Direct | |
| Jan 15, 2026 | Common Stock | MOption exerciseDisposed | −27,083 | $0.00 | $0 | 999,283 | Direct | |
| Jan 15, 2026 | Common Stock | MOption exerciseDisposed | −14,583 | $0.00 | $0 | 984,700 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.